Cbl-b-IN-2 is an orally active biological compound that inhibits the E3 enzyme Casitas b lineage lymphoma proto-oncogene b (Cbl-b) in the ubiquitin proteasome pathway and can be used in the study of diseases that modulate the immune system and are susceptible to regulation by the immune system. Cbl-b-IN-2 can also be used in cancer research alone or in combination with one or more immune checkpoint inhibitors, antitumour agents and radiopharmaceuticals.
Molecular Weight:
575.57
CAS Number:
[2503325-21-9]
Formula:
C29H30F5N5O2
Target:
Others|||E3 Ligase Ligand-Linker Conjugates
T64072
* VAT and and shipping costs not included. Errors and price changes excepted
